Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FOSAPREPITANT Cause C-reactive protein increased? 19 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 19 reports of C-reactive protein increased have been filed in association with FOSAPREPITANT. This represents 3.9% of all adverse event reports for FOSAPREPITANT.

19
Reports of C-reactive protein increased with FOSAPREPITANT
3.9%
of all FOSAPREPITANT reports
19
Deaths
19
Hospitalizations

How Dangerous Is C-reactive protein increased From FOSAPREPITANT?

Of the 19 reports, 19 (100.0%) resulted in death, 19 (100.0%) required hospitalization, and 19 (100.0%) were considered life-threatening.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT. However, 19 reports have been filed with the FAERS database.

What Other Side Effects Does FOSAPREPITANT Cause?

Dyspnoea (195) Infusion related reaction (167) Hypersensitivity (157) Duodenal ulcer perforation (155) Confusional state (149) Glossodynia (149) Folliculitis (146) Arthralgia (144) Blister (144) Discomfort (144)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which FOSAPREPITANT Alternatives Have Lower C-reactive protein increased Risk?

FOSAPREPITANT vs FOSAPREPITANT DIMEGLUMINE FOSAPREPITANT vs FOSCARBIDOPA\FOSLEVODOPA FOSAPREPITANT vs FOSCARNET FOSAPREPITANT vs FOSFOMYCIN FOSAPREPITANT vs FOSFOMYCIN TROMETHAMINE

Related Pages

FOSAPREPITANT Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased FOSAPREPITANT Demographics